Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica

Acta Academiae Medicinae Sinica ›› 2016, Vol. 38 ›› Issue (1): 103-107.doi: 10.3881/j.issn.1000-503X.2016.01.019

• Orginal Article • Previous Articles     Next Articles

Colony Stimulating Factor 3 Mutations and Myeloid Malignancies

Yi XING, Ming-feng ZHAO()   

  1. Department of Hematology,Tianjin First Central Hospital,the First Central Clinical College of Tianjin Medical University,Tianjin 300192,China
  • Received:2015-04-21 Online:2016-01-15 Published:2016-03-02
  • Supported by:
    Supported by the National Natural Sciences Foundation of China(81041043),the Natural Science Foundation of Tianjin(13JCYBJC23400),and the Health Industry Key Project of Tianjin(13KG106)


Granulocyte colony stimulating factor (G-CSF) plays a major role in the proliferation,differentiation,and activation of neutrophil cell line hematopoietic cells. G-CSF exert the function depending on its binding to colony-stimulating factor 3 receptor (CSF3R),a homo-dimer receptor located on the surface of effector cells. Some recent studies have demonstrated that CSF3R mutations play a significant role in many diseases. Some of the hematopoietic diseases,especially myeloid malignancies (e.g. chronic neutrophilic leukemia) are related to the presence of various CSF3R mutations,which leads to abnormal G-CSF signal pathways. Also,the downstream kinases can be the treatment targets for these diseases. This review summarizes CSF3R mutations,mechanisms of mutations,and their contributions to the myeloid malignancies,with an attempt to further reveal the pathogenesis of myeloid malignancies,inform the diagnosis and clinical treatment of the myeloid malignancies,and provide clues for the research and development of new molecular target drugs.

Key words: colony-stimulating factor 3 receptor, mutation, myeloid malignancy, pathogenesis

CLC Number: